Cwm, LLC Catalyst Pharmaceuticals, Inc. Transaction History

Cwm, LLC

$25.1 Billion
Q1 2025

A detailed history of Cwm, LLC transactions in Catalyst Pharmaceuticals, Inc. stock. As of the latest transaction made, Cwm, LLC holds 13,411 shares of CPRX stock, worth $340,102. This represents 0.0% of its overall portfolio holdings.

Number of Shares

13,411

Previous 11,010 21.81%

Holding current value

$340,102

Previous $230,000 41.3%

% of portfolio

0.0%

Previous 0.0%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 01, 2025	BUY	$19.53 - $25.74 $46,891 - $61,801	2,401 Added 21.81%	13,411 $325,000
Q4 2024 Feb 04, 2025	BUY	$19.73 - $23.93 $33,777 - $40,968	1,712 Added 18.41%	11,010 $230,000
Q3 2024 Oct 08, 2024	BUY	$15.19 - $21.35 $79,474 - $111,703	5,232 Added 128.68%	9,298 $185,000
Q2 2024 Jul 09, 2024	BUY	$14.68 - $16.92 $52,099 - $60,049	3,549 Added 686.46%	4,066 $63,000
Q1 2024 Apr 05, 2024	BUY	$13.18 - $17.11 $2,701 - $3,507	205 Added 65.71%	517 $8,000
Q4 2023 Feb 01, 2024	BUY	$11.78 - $17.29 $1,295 - $1,901	110 Added 54.46%	312 $5,000
Q3 2023 Oct 11, 2023	BUY	$11.69 - $15.02 $1,414 - $1,817	121 Added 149.38%	202 $2,000
Q2 2023 Aug 03, 2023	SELL	$11.5 - $18.08 $2,461 - $3,869	-214 Reduced 72.54%	81 $1,000
Q1 2023 Apr 28, 2023	BUY	$14.34 - $21.05 $2,165 - $3,178	151 Added 104.86%	295 $5,000
Q4 2022 Feb 01, 2023	BUY	$12.25 - $19.5 $1,482 - $2,359	121 Added 526.09%	144 $3,000
Q2 2022 Jul 28, 2022	SELL	$6.23 - $8.57 $3,115 - $4,285	-500 Reduced 95.6%	23 $0
Q4 2021 Jan 31, 2022	SELL	$5.21 - $7.45 $1,391 - $1,989	-267 Reduced 33.8%	523 $4,000
Q1 2021 Sep 15, 2021	BUY	$3.45 - $4.69 $1,000 - $1,360	290 Added 58.0%	790 $5,000
Q1 2021 Apr 27, 2021	SELL	$3.45 - $4.69 $1,000 - $1,360	-290 Reduced 36.71%	500 $2,000
Q4 2020 Sep 15, 2021	BUY	$2.97 - $3.83 $861 - $1,110	290 Added 58.0%	790 $5,000
Q4 2020 Jan 27, 2021	SELL	$2.97 - $3.83 $861 - $1,110	-290 Reduced 36.71%	500 $2,000
Q3 2020 Sep 15, 2021	BUY	$2.97 - $5.08 $861 - $1,473	290 Added 58.0%	790 $5,000
Q3 2020 Oct 19, 2020	SELL	$2.97 - $5.08 $861 - $1,473	-290 Reduced 36.71%	500 $1,000
Q2 2020 Sep 15, 2021	BUY	$3.48 - $5.05 $1,009 - $1,464	290 Added 58.0%	790 $5,000
Q2 2020 Jul 22, 2020	SELL	$3.48 - $5.05 $1,009 - $1,464	-290 Reduced 36.71%	500 $2,000
Q1 2020 Sep 15, 2021	BUY	$2.61 - $5.21 $756 - $1,510	290 Added 58.0%	790 $5,000
Q1 2020 Apr 28, 2020	SELL	$2.61 - $5.21 $756 - $1,510	-290 Reduced 36.71%	500 $2,000
Q4 2019 Sep 14, 2021	BUY	$3.67 - $5.7 $1,064 - $1,653	290 Added 58.0%	790 $5,000
Q4 2019 Jan 27, 2020	SELL	$3.67 - $5.7 $1,064 - $1,653	-290 Reduced 36.71%	500 $2,000
Q3 2019 Sep 14, 2021	BUY	$3.89 - $7.43 $1,128 - $2,154	290 Added 58.0%	790 $5,000
Q3 2019 Oct 22, 2019	SELL	$3.89 - $7.43 $1,128 - $2,154	-290 Reduced 36.71%	500 $3,000
Q2 2019 Sep 14, 2021	BUY	$2.7 - $6.11 $783 - $1,771	290 Added 58.0%	790 $5,000
Q2 2019 Jul 31, 2019	SELL	$2.7 - $6.11 $783 - $1,771	-290 Reduced 36.71%	500 $2,000
Q1 2019 Sep 02, 2021	BUY	$2.11 - $5.33 $611 - $1,545	290 Added 58.0%	790 $0
Q3 2017 Oct 16, 2017	BUY	$2.4 - $2.94 $1,200 - $1,470	500	500 $1,000

Others Institutions Holding CPRX

# of Institutions

389

Shares Held

99.3M

Call Options Held

37K

Put Options Held

20.5K

View Full List

About CATALYST PHARMACEUTICALS, INC.

Ticker CPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 102,820,000
Market Cap $2.61B
Description
Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...

More about CPRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cwm, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cwm, LLC with notifications on news.

Account